Clinical Trials Logo

Clinical Trial Summary

Hyperglycemia is seen in approximately 30% of patients who do not have a history of diabetes and undergo general surgery. Hyperglycemia in this setting is associated with increased risk of postoperative complications. The purpose of this study is to investigate risk factors for developing high sugars during the time of surgery, and if these high sugars can be prevented by the use of an injectable diabetes medication (dulaglutide) prior to surgery.


Clinical Trial Description

Hyperglycemia is seen in approximately 30% of patients who do not have a history of diabetes and undergo general surgery. Hyperglycemia in this setting is associated with increased risk of postoperative complications. This proposal seeks to identify underlying risk factors in the development of stress hyperglycemia, and will investigate the use of a long-acting glucagon-like peptide-1 receptor agonist for the prevention of stress hyperglycemia in a high-risk surgical population. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04862234
Study type Interventional
Source Emory University
Contact Georgia Davis, MD
Phone 404-251-8957
Email [email protected]
Status Not yet recruiting
Phase Phase 4
Start date May 2021
Completion date June 2025

See also
  Status Clinical Trial Phase
Completed NCT04058015 - Outcome of Patients With Thoraco-abdominal Injury and Stress-induced Hyperglycemia or Diabetic Hyperglycemia
Not yet recruiting NCT04797208 - Remote Glucose Monitoring in Hospital Settings N/A
Completed NCT03012867 - Enteral Nutrition and Glucose Homeostasis Phase 4
Recruiting NCT04021186 - An Optimization in the Postoperative Treatment in Head and Neck--surgical Patients. N/A
Completed NCT03094533 - TIVA and VIMA on Blood Glucose and Insulin Levels in Lung Lobectomy Patients N/A
Recruiting NCT04266015 - Anabolic Effects of Intraoperative Feeding in Reconstruction Surgery N/A